October 21, 2019
BlackThorn Therapeutics names new Chief Executive Officer
BlackThorn Therapeutics has named William J. Martin, Ph.D., as Chief Executive Officer to Lead Next Stage of Growth.
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
October 21, 2019
Odonate Therapeutics enrolls patients with Metastatic Breast Cancerin in a Phase 3 study of Tesetaxel
Odonate Therapeutics on Monday announces completion of enrollment in CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic…
October 21, 2019
Charles River Laboratories announces offering of $500 Million of senior notes
WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL–Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it intends to offer $500 million in aggregate…
October 21, 2019
Rheos Medicines welcomes Barbara S. Fox as Chief Executive Officer
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Rheos Medicines, a biopharmaceutical company harnessing insights in immunometabolism to create a new class of therapeutics for patients…
October 21, 2019
Genentech’s Tecentriq combo with Avastin increases overall survival in people with Unresectable Hepatocellular Carcinoma
Genentech’s Tecentriq’s First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival for the…
October 21, 2019
Verseau launches with $50M to develop first-in-class macrophage-targeted immunotherapies and appoints George Golumbeski as Chairman of the Board
Verseau has launched with $50M to work on PSGL-1, which has been identified as lead macrophage checkpoint modulator (MCM) program…
October 21, 2019
Circassia Pharmaceuticals launches Duaklir Pressair for Chronic Obstructive Pulmonary Disease (COPD)
Circassia Pharmaceuticals Inc. has launched Duaklir, aclidinium bromide and formoterol fumarate, for the maintenance treatment of patients with chronic obstructive…
October 18, 2019
Merck bags positive EU CHMP opinion for two new regimens of Keytruda for certain head and neck squamous cell Ccarcinoma
Merck has received positive EU CHMP opinion for two new regimens of Keytruda (pembrolizumab) as first-line ttreatment for metastatic or…
October 18, 2019
Merck nets EU CHMP positive opinion for investigational V920 ebola vaccine
Merck has received EU CHMP positive opinion for investigational V920 ebola Zaire vaccine for protection Against ebola virus disease.
October 17, 2019
Cytel to hold Complex Innovative Trial Design symposium
Cytel Inc., the leading global provider of innovative analytical software and consulting services to the life sciences industry, has announced its Complex Innovative Trial Design Symposium and East Training event, which will bring together industry-leading experts to discuss innovative solutions to pressing challenges including rare disease clinical trials, and will also offer delegates an in-depth East software training session.